Project Description


Head Office – US
Client – CEO
Role – Interim Financial Controller
Practice – Interim
Size – SME
Industry – Life Sciences


Altimmune is a clinical stage biotechnology company developing next-generation immunotherapeutics and vaccines to address significant public health and biodefense needs. By leveraging specific attributes of its two independent and complementary platform technologies, Altimmune can rapidly design product Candidates against a wide range of disease targets, including respiratory diseases, chronic infections and cancer.